Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map

Genomics

Volumn 67, Issue 1, 2000, Pages 28-39

  Wang, Pauline W ^a   Eisenbart, James D ^a   Espinosa, Rafael ^a   Davis, Elizabeth M ^a   Larson, Richard A ^a   Le Beau, Michelle M ^a  

^a University of Chicago   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTIG;

ARTICLE; CHROMOSOME 20Q; CHROMOSOME DELETION; CHROMOSOME MAP; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; EXPRESSED SEQUENCE TAG; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MYELOID LEUKEMIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION; SEQUENCE TAGGED SITE; TUMOR SUPPRESSOR GENE; UNINDEXED SEQUENCE;

EID: 0034235673     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2000.6215     Document Type: Article

References (49)

1. Aatola M., Armstrong E., Teerenhovi L., Borgström G. H. Clinical significance of the del(20q) chromosome in hematologic disorders. Cancer Genet. Cytogenet. 62:1992;75-80.
2. Asimakopoulos F. A., Gilbert J. G. R., Aldred M. A., Pearson T. C., Green A. R. Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera. Blood. 88:1996;2690-2698.
3. Asimakopoulos F. A., Green A. R. Deletions of 20q and the pathogenesis of myeloproliferative disorders. Br. J. Haematol. 95:1996;219-226.
4. Asimakopoulos F. A., White N. J., Nacheva E., Green A. R. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myeloproliferative syndromes. Blood. 84:1994;3086-3094.
5. Bench A. J., Aldred M. A., Humphray S. J., Champion K. M., Gilbert J. G. R., Asimakopoulos F. A., Deloukas P., Gwilliam R., Bentley D. R., Green A. R. A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the commonly deleted segment. Genomics. 49:1998;351-362.
6. Collins S. P., Uhler M. D. Characterization of PKIγ, a novel isoform of the protein kinase inhibitor of cAMP-dependent protein kinase. J. Biol. Chem. 272:1997;18169-18178.
7. Cordes S. P., Barsh G. S. The mouse segmentation gene kr encodes a novel basic domain-leucine zipper transcription factor. Cell. 79:1994;1025-1034.
8. Daddona P. E., Shewach D. S., Kelley W. N., Argos P., Markham A. F., Orkin S. H. Human adenosine deaminase: cDNA and complete primary amino acid sequence. J. Biol. Chem. 259:1984;12101-12106.
9. David G., van der Schueren B., Marynen P., Cassiman J. J., van den Berghe H. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J. Cell Biol. 118:1992;961-969.
10. Davis M. P., Dewald G. W., Pierre R. V., Hoagland H. C. Hematologic manifestations associated with deletions of the long arm of chromosome 20. Cancer Genet. Cytogenet. 12:1984;63-71.
11. Espinosa R. III, Le Beau M. M. Gene mapping by FISH. Boultwood J. Methods in Molecular Biology. 1996;53-76 Humana Press, Totowa.
12. Godley L. A., Lai F., Liu J., Zhao N., Le Beau M. M. TTID: A novel gene at 5q31 encoding a protein with titin-like features. Genomics. 60:1999;226-233.
13. Gorlach M., Burd C. G., Dreyfuss G. The mRNA poly(A)-binding protein: Localization, abundance, and RNA-binding specificity. Exp. Cell Res. 211:1994;400-407.
14. Graves J. D., Gotoh Y., Draves K. E., Ambrose D., Han D. K. M., Wright M., Chernoff J., Clark E., Krebs E. C. Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J. 17:1998;2224-2234.
15. Greenberg P., Cox C., Le Beau M. M., Fenaux P., Morel P., Sanz G., Sanz M., Vallespi T., Hamblin T., Oscier D., Ohyashiki O., Toyama K., Aul C., Mufti G., Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 89:1997;2079-2088.
16. Haendler B., Hofer E. Characterization of the human cyclophilin gene and of related processed pseudogenes. Eur. J. Biochem. 190:1990;477-482.
17. Heim S., Mitelman F. Cancer Cytogenetics. 1995;Wiley-Liss, New York.
18. Heinzel R., Appelhans H., Gassen G., Seemuller U., Machleidt W., Fritz H., Steffens G. Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus. Eur. J. Biochem. 160:1986;61-67.
19. Jiang Y. P., Wang H., D'Eustachio P., Musacchio J. M., Schlessinger J., Sap J. Cloning and characterization of R-PTP-kappa, a new member of the receptor protein tyrosine phosphatase family with a proteolytically cleaved cellular adhesion molecule-like extracellular region. Mol. Cell. Biol. 13:1993;2942-2951.
20. Kirchhoff C., Habben I., Ivell R., Krull N. A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol. Reprod. 45:1991;350-357.
21. Lamprecht R. CREB: A message to remember. Cell. Mol. Life Sci. 55:1999;554-563.
22. Le Beau M. M., Westbrook C. A., Diaz M. O., Rowley J. D. c-src is consistently conserved in the chromosomal deletion (20q) observed in myeloid disorders. Proc. Natl. Acad. Sci. USA. 82:1985;6692-6696.
23. Lee K.-K., Murakawa M., Nishida E., Tsubuki S., Kawashima S., Sakamaki K., Yonehara S. Proteolytic activation of MST/Krs, STE20-related protein kinase, by caspase during apoptosis. Oncogene. 16:1998;3029-3037.
24. Leffers H., Madsen P., Rasmussen H. H., Honore B., Andersen A. H., Walbum E., Vandekerckhove J., Celis J. E. Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway. J. Mol. Biol. 231:1993;982-998.
25. Lilja H., Abrahamsson P. A., Lundwall A. Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa. J. Biol. Chem. 264:1989;1894-1900.
26. Lilja H., Lundwall A. Molecular cloning of epididymal and seminal vesicular transcripts encoding a semenogelin-related protein. Proc. Natl. Acad. Sci. USA. 89:1992;4559-4563.
27. McAndrew P. E., Frostholm A., Evans J. E., Zdilar D., Goldowitz D., Chiu I.-M., Burghes A. H. M., Rotter A. Novel receptor protein tyrosine phosphatase (RPTP rho) and acidic fibroblast growth factor (FGF-1) transcripts delineate a rostrocaudal boundary in the granule cell layer of the murine cerebellar cortex. J. Comp. Neurol. 391:1998;444-455.
28. Minoguchi S., Taniguchi Y., Kato H., Okazaki T., Strobl L. J., Zimber-Strobl U., Bornkamm G. W., Honjo T. RBP-L, a transcription factor related to RBP-Jkappa. Mol. Cell. Biol. 17:1997;2679-2687.
29. Mitelman F. ISCN: An International System for Human Cytogenetic Nomenclature. 1995;Karger, Basel.
30. Morrish D. W., Dakour J., Li H. Cloning of PL33: A novel probable serpentine membrane receptor associated with human cytotrophoblast and lineage-specific HL-60 cell differentiation. Mol. Cell. Endocrinol. 120:1996;147-151.
31. Nacheva E., Holloway T., Carter N., Grace C., White N., Green A. R. Characterization of 20q deletions in patients with myeloproliferative disorders or myelodysplastic syndromes. Cancer Genet. Cytogenet. 80:1995;87-94.
32. Nuttall S. D., Hanson B. J., Mori M., Hoogenraad N. J. hTOM34: A novel translocase for the import of proteins into human mitochondria. DNA Cell. Biol. 16:1997;1067-1074.
33. Rapp G., Freudenstein J., Klaudiny J., Mucha J., Wempe F., Zimmer M., Scheit K. H. Characterization of three abundant mRNAs from human ovarian granulosa cells. DNA Cell. Biol. 9:1990;479-485.
34. Rossi F., Labourier E., Forné T., Divita G., Derancourt J., Riou J. F., Antoine E., Cathala G., Brunel C., Tazi J. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature. 381:1996;80-82.
35. Roulston D., Espinosa R. III, Stoffel M., Bell G. I., Le Beau M. M. Molecular genetics of myeloid leukemia: Identification of the commonly deleted segment of chromosome 20. Blood. 82:1993;3424-3429.
36. Sallenave J. M., Silva A. Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions. Am. J. Respir. Cell. Mol. Biol. 8:1993;439-445.
37. Schlessinger J. Phospholipase Cγ activation and phosphoinositide hydrolysis are essential for embryonal development. Proc. Natl. Acad. Sci. USA. 94:1997;2798-2799.
38. Screaton G. R., Caceras J. F., Mayeda A., Bell M. V., Plebanski M., Jackson D. G., Bell J. I., Krainer A. R. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J. 14:1995;4336-4349.
39. Stocker M., Kerschensteiner D. Cloning and tissue distribution of two new potassium channel α-subunits from rat brain. Biochem. Biophys. Res. Commun. 248:1998;927-934.
40. Stoffel M., Le Beau M. M., Espinosa R. III, Bohlander S., Le Paslier D., Cohen D., Xiang K.-S., Cox N. J., Fajans S. S., Bell G. I. A yeast artificial chromosome-based map of the region of chromosome 20 containing the diabetes-susceptibility gene, MODY1, and a myeloid leukemia related gene. Proc. Natl. Acad. Sci. USA. 93:1996;3937-3941.
41. Taylor L. K., Wang H. C. R., Erikson R. L. Newly identified stress-responsive protein kinases, Krs-1 and Krs-2. Proc. Natl. Acad. Sci. USA. 93:1996;10099-10104.
42. Waldegger S., Barth P., Raber G., Lang F. Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonic and isotonic alterations of cell volume. Proc. Natl. Acad. Sci. USA. 94:1997;4440-4445.
43. Wang P. W., Eisenbart J. D., Cordes S. P., Barsh G. S., Stoffel M., Le Beau M. M. Human KRML (MAFB): cDNA cloning, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias. Genomics. 59:1999;275-281.
44. Wang P. W., Iannantuoni K., Davis E. M., Stoffel M., Le Beau M. M. Refinement of the commonly deleted segment in myeloid leukemias with a del(20q). Genes Chromosomes Cancer. 21:1998;75-81.
45. Wattel E., Lai J. L., Hebbar M., Preudhomme C., Grahek D., Morel P., Bauters F., Fenaux P. De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: A subtype of MDS with distinct hematologic and prognostic features? Leukemia Res. 17:1993;921-926.
46. Weston K. Myb proteins in life, death, and differentiation. Curr. Opin. Genet. Dev. 8:1998;76-81.
47. Wismar J., Loffler T., Habtemichael N., Vef O., Geissen M., Zirwes R., Altmeyer W., Sass H., Gateff E. The Drosophila melanogaster tumor suppressor gene lethal(3) malignant brain tumor encodes a proline-rich protein with a novel zinc finger. Mech. Dev. 53:1995;141-154.
48. Yamagata K., Furuta H., Oda N., Kaisaki P. J., Menzel S., Cox N. J., Fajans S. S., Signorini S., Stoffel M., Bell G. I. Mutations in the hepatocyte nuclear factor-4 alpha gene in maturity-onset diabetes of the young. Nature. 384:1996;458-460.
49. Zhao N., Stoffel A., Wang P. W., Eisenbart J. D., Espinosa R. III, Larson R. A., Le Beau M. M. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid disease to 1-1.5 MB and preparation of a PAC-based physical map. Proc. Natl. Acad. Sci. USA. 94:1997;6948-6953.